ÂÜÀòÂÒÂ×

Hongtao Zhao is a Computational Chemist specializing in drug discovery, with extensive knowledge in compound design, virtual screening, library design, cheminformatics, biophysics, and artificial intelligence. They are currently an Associate Principal Scientist in Computational Chemistry at AstraZeneca, having held a similar position at Medivir AB from 2015 to 2018. Hongtao's academic background includes a PhD in computer-aided drug design from the University of Zurich and a Master's in Analytical Chemistry from Nanjing University, where they also completed their Bachelor's degree in Chemistry. They serve as a reviewer for several scientific journals, including Current Medicinal Chemistry and MedChemComm.